World High Life PLC Announces Total Voting Rights
LONDON, UK / ACCESSWIRE / February 1, 2021 / World High Life PLC ("World High Life" or the "Company") (LSE:LIFE)(OTCQB:WRHLF): For the...
Year: 2021
Nationwide Medication Savings Leader Prescription Hope is Helping People Achieve their New Year’s Resolution to Save Money
STUART, FL / ACCESSWIRE / February 1, 2021 / Prescription Hope, one of the largest patient assistance program administrators in...
How Advancements of extracorporeal life support technology is Spurring Growth of Centrifugal blood pump Market: New Report Analyses
Key market players are aiming at strategic alliances with service providers to address the requirements of an expanding patient base....
ENB Therapeutics Demonstrated Early Efficacy in Phase I Clinical Trial of ENB-003 in Combination with Pembrolizumab
ENB-003 is the Company's first in class small molecule therapeutic selectively targeting the ETB receptor - a novel immune checkpoint...
Halberd Corporation’s CEO Interviewed on The Stock Day Podcast and on MoneyTV
JACKSON CENTER, PA / ACCESSWIRE / February 1, 2021 / Halberd Corporation's (OTC PINK:HALB) Chairman, President & CEO, William A....
9 Meters Biopharma, Inc. Announces Research & Development Day on Short Bowel Syndrome
SAVE THE DATE: Webinar Scheduled for March 23, 2021 @ 11 AM ET RALEIGH, NC / ACCESSWIRE / February 1,...
Kadmon Announces Publication of Preclinical Data Demonstrating Anti-PD-L1/IL-15 Fusion Protein KD033 Achieves Robust Anti-Tumor Response
NEW YORK, NY / ACCESSWIRE / February 1, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced the publication of preclinical...
Pharma-Bio Serv Announces Results for the Year Ended October 31, 2020
DORADO, PUERTO RICO / ACCESSWIRE / February 1, 2021 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), is...
Theralase(R) Releases Quarterly Newsletter
TORONTO, ON / ACCESSWIRE / February 1, 2021 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
Sonnet BioTherapeutics Completes Successful Repeat Dose Study of SON-1010 in Non-Human Primates
The toxicity effects of SON-1010 were well tolerated at doses exceeding levels expected in future human clinical trials, without producing...
Lexaria Provides Guidance on Upcoming R&D
KELOWNA, BC / ACCESSWIRE / February 1, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator...
Genesys Industries, Inc. Corporate Update
CALGARY, ALBERTA, Feb. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Genesys Industries, Inc. (OTC Pink: GEIN) (the “Company”) is...
National Basketball Retired Players Association, Sheryl Swoopes and Flexion Therapeutics Announce Partnership to Raise Awareness of ZILRETTA®
- Sheryl Swoopes, WNBA Legend, Basketball Hall of Famer and ZILRETTA Patient, Tips Off Educational Campaign About ZILRETTA and Osteoarthritis Knee...
Chiesi Group receives the European Marketing authorization for the extrafine triple-combination therapy for the treatment of moderate to severe asthma
It is the first extrafine fixed triple combination therapy in a single inhaler to be approved for use in asthma...
ATEC Opens New Headquarters with Substantially Increased Sales and Surgeon Education Capacity
CARLSBAD, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative spine surgery solutions...
SetPoint Medical Announces First Patient Enrolled in the RESET-RA Study
Pivotal IDE Study will evalute SetPoint’s propriertary bioelectronic device for treatment of Rheumatoid ArthritisVALENCIA, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE)...
Protech Home Medical Reports Strong Fourth Quarter and Record Audited Full Year Fiscal 2020 Financial Results
Posts Q4 Revenue Growth of 28% and Adjusted EBITDA Growth of 69%CINCINNATI, Ohio, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Protech...
Philips expands remote patient management with the introduction of Medical Tablet with advanced software
Philips Medical Tablet Physicians Consult with Philips Medical Tablet February 1, 2021 New solution available in North America, Europe and...
BBS-Bioactive Bone Substitutes Plc: CFO will change on 1 February, 2021
BBS-Bioactive Bone Substitutes Plc, Company Announcement on 1 February 2021 at 3:35 pm (UTC +2:00) MSc. (Tech) Liisa Hukka from...
PureK Holdings Corp., a Plant-Based Wellness Company, Signs Definitive Agreement to Acquire No B.S. Skincare, a Clean Ingredient Skincare Company
No B.S. Brands No B.S. Skincare No B.S. Skincare Products to Become Available on Target.com Beginning in February 2021 VANCOUVER,...